ML Bio Solutions, Inc.
Quick facts
Phase 3 pipeline
- BBP-418 (ribitol)
BBP-418 is a ribitol-based compound that modulates immune or metabolic pathways, though its precise mechanism remains proprietary.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about ML Bio Solutions, Inc.
What is ML Bio Solutions, Inc.'s pipeline?
ML Bio Solutions, Inc. has 1 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include BBP-418 (ribitol).
Related
- Sector hub: All tracked pharma companies